US › Healthcare

IRIDEX Corporation (IRIX)

US · Healthcare · Medical Devices

$0.65+7.36%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$12.6M

Revenue YoY

-7.4%

Net profit

$-1.3M

EPS

$-0.07

EPS estimate

$-0.01

Net margin

-10.1%

EPS came in at -0.07 against a street estimate of -0.01 — a miss of 600.0%.

Key statistics

Market cap

$11.6M

Forward P/E

769.2

P/B

331.20

Book value

$-0.14

EPS (TTM)

$-0.20

52-week high

$1.65

52-week low

$0.65

50-day MA

$0.86

200-day MA

$1.10

Beta

0.63

Analyst view

with an average price target of $2.75.

Shareholding

Insiders

36.76%

Institutions

19.46%

Largest institutional holders

Fund	Stake
PARAGON Assoc & PARAGON Assoc II JV	5.69%
Vanguard Capital Management, LLC	2.93%
Renaissance Technologies Corp	2.26%
Weber Capital Management LLC	1.03%
Geode Capital Management, LLC	0.91%
Citadel Advisors Llc	0.56%
Vanguard Fiduciary Trust Co	0.34%
United Capital Financial Advisers Inc	0.33%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for IRIDEX Corporation — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.